← All companies

CASI

CASI Pharmaceuticals, Inc.

CASIF OTC Pharmaceutical Preparations EDGAR ↗

$0.13

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$2.67M

Revenue (TTM)

$20.7M

Net income (TTM)

-$48.1M

EPS (TTM)

$-2.59

P/E ratio

—

Dividend yield

—

Free cash flow

-$20.8M

Cash

$5.63M

Total assets

$25.6M

Gross margin

48.6%

52-week range

$0.05 – $3.09

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 15, 2026 6-K FORM 6-K Jun 29, 2026 6-K FORM 6-K Jun 2, 2026 20-F May 15, 2026 6-K FORM 6-K Apr 20, 2026 6-K FORM 6-K Apr 20, 2026 6-K FORM 6-K Apr 15, 2026 6-K FORM 6-K Mar 3, 2026 6-K FORM 6-K Feb 25, 2026 6-K FORM 6-K Feb 20, 2026 6-K FORM 6-K Feb 19, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Jan 22, 2026 6-K FORM 6-K Jan 13, 2026 6-K FORM 6-K Dec 31, 2025 6-K FORM 6-K Dec 23, 2025 6-K FORM 6-K Dec 11, 2025 6-K FORM 6-K Nov 19, 2025 6-K FORM 6-K Nov 14, 2025 6-K FORM 6-K Nov 10, 2025 6-K FORM 6-K Sep 26, 2025 6-K FORM 6-K Sep 2, 2025 6-K FORM 6-K Aug 29, 2025 6-K FORM 6-K Aug 27, 2025 6-K FORM 6-K Aug 4, 2025 6-K FORM 6-K Jul 22, 2025 6-K FORM 6-K May 20, 2025 6-K/A FORM 6-K/A May 20, 2025 6-K FORM 6-K May 16, 2025 6-K FORM 6-K May 14, 2025 6-K FORM 6-K May 12, 2025 6-K FORM 6-K May 7, 2025 6-K FORM 6-K Apr 9, 2025 6-K FORM 6-K Apr 3, 2025 6-K FORM 6-K Apr 3, 2025 20-F Mar 31, 2025 6-K FORM 6-K Mar 31, 2025 6-K Feb 10, 2025 6-K FORM 6-K Jan 21, 2025 6-K FORM 6-K Dec 26, 2024